I thought, and still do, that this was an exciting bit of news. Yes, we should temper our enthusiasm, but this is a promising drug. It appears to improve pft measures above and beyond all of our current treatments. Just because the trial is powered to pass through the FDA as quickly as possible, doesn't mean it won't help people with lower PFTs (<75%). That said, it's understandable to be upset you can't participate in the trial.
I don't know exact dollars, but from what I can tell, CF research is very well funded. While Chris Rock has many valid points, I think the cure is also significantly harder to find than sympomatic treatments. But this is precisely why this drug is so exciting. It's not just another antibiotic or mucolytic, but it's going to the source of the defect.
-James 32 w/ cf
I don't know exact dollars, but from what I can tell, CF research is very well funded. While Chris Rock has many valid points, I think the cure is also significantly harder to find than sympomatic treatments. But this is precisely why this drug is so exciting. It's not just another antibiotic or mucolytic, but it's going to the source of the defect.
-James 32 w/ cf